Project Overview
WHO-GMP certified pharmaceutical manufacturing facility producing essential medicines for West African market
Quick Summary
Integrated plant producing tablets, capsules, and injectables with capacity for export
Project Details
Project Information
Type: Greenfield Project
Stage: Concept Stage
Location Details
Country: Nigeria
Specific Location: Lagos State, Nigeria
Financial Information
$30M – $45M
Investment Range
21.00%
Expected ROI
Payback Period
5
Investment Incentives & Support
Detailed incentive information is available from the Investment Promotion Agency. Please contact them directly for the latest incentive packages.
Location Information
Project Location
Country: Nigeria
Specific Location: Lagos State, Nigeria
Location Advantages
- Strategic location in West Africa
- Access to Nigeria market
- ECOWAS regional market access
Risk Assessment & FAQ
Frequently Asked Questions
The investment approval process typically involves application submission to the IPA,
project evaluation, regulatory approvals, and final licensing. Contact the IPA for
specific requirements and timelines.
Nigeria offers various investment incentives including
tax holidays, duty exemptions, and other fiscal incentives. Contact the IPA for a complete
incentive package tailored to your investment.
Foreign ownership rules vary by sector. Nigeria
generally allows 100% foreign ownership in most sectors. Contact the IPA for sector-specific
requirements and any local partnership obligations.
The implementation timeline depends on project complexity, approvals, and construction.
Contact the IPA for a detailed project timeline and milestone schedule.
